Serotonin syndrome.

Abstract

Serotonin syndrome usually occurs after treatment with monoamine oxydase inhibitors and drugs that enhance serotoninergic transmission. Serotonin agents, such as Proza, are commonly prescribed drugs; therefore, the serotonin syndrome appears more frequently than before. Clinicians must be able to prevent, recognize, and treat this syndrome in their practice. This review summarizes the literature of case reports of patients who developed the serotonin syndrome.

• Authors: Z Ivanusa, H Hećimović, V Demarin
• Journal: Neuropsychiatry, neuropsychology, and behavioral neurology (Neuropsychiatry Neuropsychol Behav Neurol) Vol. 10 Issue 3 Pg. 209-12 (Jul 1997) ISSN: 0894-878X [Print] United States
• PMID: 9297715 (Publication Type: Journal Article, Review)

Chemical References

• Monoamine Oxidase Inhibitors
• Receptors, Serotonin
• Serotonin Agents
• Fluoxetine
• Serotonin

Topics

• Fluoxetine (adverse effects, therapeutic use)
• Humans
• Monoamine Oxidase Inhibitors (administration & dosage, adverse effects)
• Nervous System Diseases (chemically induced, diagnosis, physiopathology)
• Receptors, Serotonin (drug effects, physiology)
• Serotonin (physiology)
• Serotonin Agents (administration & dosage, adverse effects)
• Substance-Related Disorders (diagnosis, physiopathology)
• Synaptic Transmission (drug effects, physiology)
• Syndrome